{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/596605543",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/2121804732"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1075842300"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#596605543",
  "code": "XM9G63",
  "source": "http://id.who.int/icd/entity/596605543",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Anticholinergics predominantly used for Parkinson disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/2082382492",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/2082382492"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Muscle relaxants, centrally acting"
      },
      "foundationReference": "http://id.who.int/icd/entity/653486448",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/653486448"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Lisuride"
      },
      "foundationReference": "http://id.who.int/icd/entity/431701449",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/431701449"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Antiparkinson drugs"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Antiparkinson drugs"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Antiparkinsonism drug"
      }
    }
  ]
}